{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:23:14Z","timestamp":1793305394577,"version":"4.5.0"},"reference-count":66,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Select patients with colorectal cancer with peritoneal metastases may undergo a curative-intent cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy after neoadjuvant systemic chemotherapy. Factors predicting pathologic complete response (CR) remain poorly defined, as do eligibility criteria for this aggressive therapy. We aimed to evaluate the pathologic CR rate following neoadjuvant chemotherapy and develop a predictive model for treatment response to optimize patient selection and benefit-risk assessment within the personalized medicine framework.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-center retrospective cohort study included 178 patients treated with neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy between 2003 and 2019. After analyzing demographic, clinicopathologic, and perioperative variables, we performed a multivariate analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The median peritoneal carcinomatosis index was 9, complete cytoreduction was achieved in 88.7% of patients, and pathologic CR was observed in 19 (10.7%) patients. Tumor histological subtype, lymph node involvement, vascular invasion, and peritoneal carcinomatosis index were statistically significantly associated with histologic response (P\u2009=\u2009.016, P\u2009=\u2009.032, P\u2009=\u2009.035, and P\u2009&amp;lt;\u2009.001, respectively). In multivariate analysis, tumor histologic subtype was the only independent predictor of response (odds ratio, 0.271 [95% CI, 0.075-0.988], P\u2009=\u2009.048) and was used to generate a logistic regression model with moderate discriminative performance (area under the curve\u2009=\u20090.638 [95% CI, 0.519-0.757], P\u2009=\u2009.049). Mucinous histology is a negative prognostic factor, with approximately 3-fold lower probability of achieving pathologic CR compared with enteroid type.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Although larger prospective studies are needed to validate these findings, our model supports the potential integration of histologic subtype into prognostic scoring systems to better define criteria for selecting patients more bound to respond to this aggressive therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajcp\/aqag055","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T11:36:19Z","timestamp":1777116979000},"source":"Crossref","is-referenced-by-count":1,"title":["Factors predicting histopathologic response to neoadjuvant chemotherapy in patients with peritoneal metastases from colorectal cancer"],"prefix":"10.1093","volume":"165","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5220-0805","authenticated-orcid":false,"given":"Coca-Mihaela","family":"Vieru","sequence":"first","affiliation":[{"name":"Department of Pathology, Hospital Central de la Defensa G\u00f3mez Ulla , Madrid,","place":["Spain"]},{"name":"Affiliated to the doctorate programme of the Department of Surgery, Complutense University of Madrid , Madrid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenceslao","family":"V\u00e1squez Jim\u00e9nez","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Hospital General Universitario Gregorio Mara\u00f1\u00f3n , Madrid,","place":["Spain"]},{"name":"Department of Surgery, Complutense University of Madrid , Madrid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Mateo Sierra","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Instituto de Investigaci\u00f3n Hospital Gregorio Mara\u00f1\u00f3n, Hospital General Universitario Gregorio Mara\u00f1\u00f3n , Madrid,","place":["Spain"]},{"name":"Department of Surgery, Complutense University of Madrid , Madrid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Sola Vendrell","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Complutense University of Madrid , Madrid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jes\u00fas","family":"Fern\u00e1ndez Ace\u00f1ero","sequence":"additional","affiliation":[{"name":"Department of Pathology and Instituto de Investigaci\u00f3n Cl\u00ednico San Carlos, Hospital Cl\u00ednico San Carlos , Madrid,","place":["Spain"]},{"name":"Department of Legal Medicine, Psychiatry and Pathology, Complutense University of Madrid , Madrid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"key":"2026061312294844700_aqag055-B1","doi-asserted-by":"publisher","first-page":"650098","DOI":"10.3389\/fonc.2021.650098","article-title":"Peritoneal metastases from colorectal cancer: defining and addressing the challenges","volume":"11","author":"Kranenburg","year":"2021","journal-title":"Front Oncol"},{"key":"2026061312294844700_aqag055-B2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10585-015-9719-0","article-title":"Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases","volume":"32","author":"van der Geest","year":"2015","journal-title":"Clin Exp Metastasis"},{"key":"2026061312294844700_aqag055-B3","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.canep.2014.04.004","article-title":"Patterns of metachronous metastases after curative treatment of colorectal cancer","volume":"38","author":"van Gestel","year":"2014","journal-title":"Cancer Epidemiol"},{"key":"2026061312294844700_aqag055-B4","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/annonc\/mdt591","article-title":"Metastatic pattern in colorectal cancer is strongly influenced by histological subtype","volume":"25","author":"Hugen","year":"2014","journal-title":"Ann Oncol"},{"key":"2026061312294844700_aqag055-B5","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1002\/ijc.25596","article-title":"Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study","volume":"128","author":"Lemmens","year":"2011","journal-title":"Int J Cancer"},{"key":"2026061312294844700_aqag055-B6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/codi.12552","article-title":"Individualized prediction of risk of metachronous peritoneal carcinomatosis from colorectal cancer","volume":"16","author":"Segelman","year":"2014","journal-title":"Colorectal Dis"},{"key":"2026061312294844700_aqag055-B7","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/codi.13219","article-title":"External validation of models predicting the individual risk of metachronous peritoneal carcinomatosis from colon and rectal cancer","volume":"18","author":"Segelman","year":"2016","journal-title":"Colorectal Dis"},{"key":"2026061312294844700_aqag055-B8","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/bjs5.50247","article-title":"Overall risk and risk factors for metachronous peritoneal metastasis after colorectal cancer surgery: a nationwide cohort study","volume":"4","author":"Ravn","year":"2020","journal-title":"BJS Open"},{"key":"2026061312294844700_aqag055-B9","doi-asserted-by":"publisher","first-page":"7896","DOI":"10.1245\/s10434-022-12097-9","article-title":"Prediction of metachronous peritoneal metastases after radical surgery for colon cancer: a scoring system obtained from an international multicenter cohort","volume":"29","author":"Pedrazzani","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"2026061312294844700_aqag055-B10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4251\/wjgo.v15.i1.112","article-title":"Development and validation of a nomogram for predicting metachronous peritoneal metastasis in colorectal cancer: a retrospective study","volume":"15","author":"Ban","year":"2023","journal-title":"World J Gastrointest Oncol"},{"key":"2026061312294844700_aqag055-B11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jamcollsurg.2007.04.039","article-title":"Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases","volume":"205","author":"Miller","year":"2007","journal-title":"J Am Coll Surg"},{"key":"2026061312294844700_aqag055-B12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.14701\/kjhbps.2016.20.3.110","article-title":"Aggressive surgical resection for concomitant liver and lung metastasis in colorectal cancer","volume":"20","author":"Lee","year":"2016","journal-title":"Korean J Hepato-Biliary-Pancreat Surg"},{"key":"2026061312294844700_aqag055-B13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/00000658-199502000-00002","article-title":"Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"key":"2026061312294844700_aqag055-B14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/00000658-199402000-00001","article-title":"Pseudomyxoma peritonei a cancer whose biology is characterized by a redistribution phenomenon","volume":"219","author":"Sugarbaker","year":"1994","journal-title":"Ann Surg"},{"key":"2026061312294844700_aqag055-B15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1245\/s10434-006-9185-7","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement","volume":"14","author":"Esquivel","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"2026061312294844700_aqag055-B16","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","article-title":"8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"15","author":"Verwaal","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"2026061312294844700_aqag055-B17","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00268-014-2801-y","article-title":"Implementation of a Standardized HIPEC protocol improves outcome for peritoneal malignancy","volume":"39","author":"Kuijpers","year":"2015","journal-title":"World J Surg"},{"key":"2026061312294844700_aqag055-B18","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1245\/s10434-019-07294-y","article-title":"Impact of synchronous versus metachronous onset of colorectal peritoneal metastases on survival outcomes after cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC): a multicenter, retrospective, observational study","volume":"26","author":"Hentzen","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"2026061312294844700_aqag055-B19","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","article-title":"Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin","volume":"27","author":"Elias","year":"2009","journal-title":"J Clin Oncol"},{"key":"2026061312294844700_aqag055-B20","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1245\/s10434-009-0875-9","article-title":"Critical assessment of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei","volume":"17","author":"Saxena","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"2026061312294844700_aqag055-B21","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1245\/s10434-013-3223-z","article-title":"Morbidity and mortality of cytoreduction with intraperitoneal chemotherapy: outcomes from the ACS NSQIP database","volume":"21","author":"Bartlett","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"2026061312294844700_aqag055-B22","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1007\/s11605-014-2477-5","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: outcomes from a single tertiary institution","volume":"18","author":"Tabrizian","year":"2014","journal-title":"J Gastrointest Surg"},{"key":"2026061312294844700_aqag055-B23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3978\/j.issn.2078-6891.2015.100","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality","volume":"7","author":"Newton","year":"2016","journal-title":"J Gastrointest Oncol"},{"key":"2026061312294844700_aqag055-B24","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/SLA.0b013e3181a45d86","article-title":"Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? A systematic review of morbidity and mortality","volume":"249","author":"Chua","year":"2009","journal-title":"Ann Surg"},{"key":"2026061312294844700_aqag055-B25","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/SLA.0b013e31825704e3","article-title":"Identification of a subgroup of patients at highest risk for complications after surgical cytoreduction and hyperthermic intraperitoneal chemotherapy","volume":"256","author":"Baratti","year":"2012","journal-title":"Ann Surg"},{"key":"2026061312294844700_aqag055-B26","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jamcollsurg.2010.05.019","article-title":"Laparoscopic surgery for cancer: a systematic review and a way forward","volume":"211","author":"Angst","year":"2010","journal-title":"J Am Coll Surg"},{"key":"2026061312294844700_aqag055-B27","doi-asserted-by":"publisher","first-page":"e186847","DOI":"10.1001\/jamanetworkopen.2018.6847","article-title":"Morbidity and mortality rates following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy compared with other high-risk surgical oncology procedures","volume":"2","author":"Foster","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2026061312294844700_aqag055-B28","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/SLA.0000000000006492","article-title":"Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy and liver resection is a treatment option for patients with peritoneal and liver metastases from colorectal cancer","volume":"280","author":"Dagenborg","year":"2024","journal-title":"Ann Surg"},{"key":"2026061312294844700_aqag055-B29","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Qu\u00e9net","year":"2021","journal-title":"Lancet Oncol"},{"key":"2026061312294844700_aqag055-B30","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","article-title":"A genetic model for colorectal tumorigenesis","volume":"61","author":"Fearon","year":"1990","journal-title":"Cell"},{"key":"2026061312294844700_aqag055-B31","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nature11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","author":"Cancer Genome Atlas Network","year":"2012","journal-title":"Nature"},{"key":"2026061312294844700_aqag055-B32","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat Med"},{"key":"2026061312294844700_aqag055-B33","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1200\/JCO.2008.19.8168","article-title":"KRAS mutations and sensitivity to epidermal growth factor receptor inhibitors in colorectal cancer: practical application of patient selection","volume":"27","author":"Jimeno","year":"2009","journal-title":"J Clin Oncol Off J Col"},{"key":"2026061312294844700_aqag055-B34","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/PPO.0b013e31819e3202","article-title":"KRAS mutations and susceptibility to cetuximab and panitumumab in colorectal cancer","volume":"15","author":"Jimeno","year":"2009","journal-title":"Cancer J Sudbury J"},{"key":"2026061312294844700_aqag055-B35","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ctrv.2008.11.005","article-title":"Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR","volume":"35","author":"Heinemann","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"2026061312294844700_aqag055-B36","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3109\/0284186X.2014.895036","article-title":"The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: a systematic review and meta-analysis","volume":"53","author":"Therkildsen","year":"2014","journal-title":"Acta Oncol"},{"key":"2026061312294844700_aqag055-B37","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.ejso.2016.03.014","article-title":"Histological subtype and systemic metastases strongly influence treatment and survival in patients with synchronous colorectal peritoneal metastases","volume":"42","author":"Simkens","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"2026061312294844700_aqag055-B38","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12957-025-03873-4","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio and CA 19\u20139 in overall survival of patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"23","author":"Nie","year":"2025","journal-title":"World J Surg Oncol"},{"key":"2026061312294844700_aqag055-B39","doi-asserted-by":"publisher","first-page":"10572","DOI":"10.1038\/s41598-019-46819-z","article-title":"A set of molecular markers predicts chemosensitivity to mitomycin-C following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastasis","volume":"9","author":"Shannon","year":"2019","journal-title":"Sci Rep"},{"key":"2026061312294844700_aqag055-B40","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/dc.70009","article-title":"Liquid biopsy in CRC management: early detection, minimal residual disease, and therapy optimization\u2014clinical evidence and challenges","volume":"53","author":"Liu","year":"2025","journal-title":"Diagn Cytopathol"},{"key":"2026061312294844700_aqag055-B41","doi-asserted-by":"publisher","first-page":"893","DOI":"10.2147\/CMAR.S519094","article-title":"Recurrence prediction by multi-omics in the patient with colorectal peritoneal metastases after cytoreductive surgery: a prospective biomarker study","volume":"17","author":"Chen","year":"2025","journal-title":"Cancer Manag Res"},{"key":"2026061312294844700_aqag055-B42","doi-asserted-by":"publisher","first-page":"12487","DOI":"10.1038\/s41598-024-63366-4","article-title":"CILP2 is a potential biomarker for the prediction and therapeutic target of peritoneal metastases in colorectal cancer","volume":"14","author":"Ha","year":"2024","journal-title":"Sci Rep"},{"key":"2026061312294844700_aqag055-B43","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1039\/D3AN00627A","article-title":"Deep learning for the prediction of the chemotherapy response of metastatic colorectal cancer: comparing and combining H&E staining histopathology and infrared spectral histopathology","volume":"148","author":"Brunel","year":"2023","journal-title":"Analyst"},{"key":"2026061312294844700_aqag055-B44","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1007\/s00261-025-05201-6","article-title":"Radiomics-based artificial intelligence (AI) models in colorectal cancer (CRC) diagnosis, metastasis detection, prognosis, and treatment response prediction","volume":"51","author":"Elahi","year":"2026","journal-title":"Abdom Radiol (NY)"},{"key":"2026061312294844700_aqag055-B45","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.2147\/CMAR.S517949","article-title":"Development and cross-institutional validation of a comprehensive machine learning model predicting response to neoadjuvant therapy for rectal cancer","volume":"17","author":"Li","year":"2025","journal-title":"Cancer Manag Res"},{"key":"2026061312294844700_aqag055-B46","doi-asserted-by":"publisher","first-page":"109463","DOI":"10.1016\/j.ejso.2024.109463","article-title":"Response prediction for neoadjuvant treatment in locally advanced rectal cancer patients\u2014improvement in decision-making: a systematic review","volume":"51","author":"Boldrini","year":"2025","journal-title":"Eur J Surg Oncol"},{"key":"2026061312294844700_aqag055-B47","doi-asserted-by":"publisher","first-page":"e7251","DOI":"10.1002\/cam4.7251","article-title":"A dynamic nomogram for predicting pathologic complete response to neoadjuvant chemotherapy in locally advanced rectal cancer","volume":"13","author":"Wang","year":"2024","journal-title":"Cancer Med"},{"key":"2026061312294844700_aqag055-B48","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1245\/s10434-014-3647-0","article-title":"Pathological response to neoadjuvant chemotherapy: a new prognosis tool for the curative management of peritoneal colorectal carcinomatosis","volume":"21","author":"Passot","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"2026061312294844700_aqag055-B49","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1111\/codi.15368","article-title":"Prospective correlation of the radiological, surgical and pathological findings in patients undergoing cytoreductive surgery for colorectal peritoneal metastases: implications for the preoperative estimation of the peritoneal cancer index","volume":"22","author":"Bhatt","year":"2020","journal-title":"Colorectal Dis Off Dis"},{"key":"2026061312294844700_aqag055-B50","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1245\/s10434-020-08234-x","article-title":"The pathologic peritoneal cancer index (PCI) strongly differs from the surgical PCI in peritoneal metastases arising from various primary tumors","volume":"27","author":"Bhatt","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"2026061312294844700_aqag055-B51","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000513353","article-title":"The accuracy of the surgical peritoneal cancer index in patients with peritoneal metastases of colorectal cancer","volume":"38","author":"De Boer","year":"2021","journal-title":"Dig Surg"},{"key":"2026061312294844700_aqag055-B52","doi-asserted-by":"publisher","first-page":"8560","DOI":"10.1245\/s10434-024-16035-9","article-title":"Correlation of morphological appearance of peritoneal lesions at laparotomy and disease at pathological assessment in patients undergoing cytoreductive surgery for peritoneal malignancy: results of phase I of the PRECINCT study in 707 Patients","volume":"31","author":"Bhatt","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"2026061312294844700_aqag055-B53","doi-asserted-by":"publisher","first-page":"3840","DOI":"10.1245\/s10434-020-09330-8","article-title":"Clinical and radiologic predictors of a pathologic complete response to neoadjuvant chemotherapy (NACT) in patients undergoing cytoreductive surgery for colorectal peritoneal metastases: results of a prospective multi-center study","volume":"28","author":"Bhatt","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"2026061312294844700_aqag055-B54","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1515\/pp-2016-0011","article-title":"Peritoneal sampling and histological assessment of therapeutic response in peritoneal metastasis: proposal of the Peritoneal Regression Grading Score (PRGS)","volume":"1","author":"Solass","year":"2016","journal-title":"Pleura Peritoneum"},{"key":"2026061312294844700_aqag055-B55","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1111\/his.13829","article-title":"Reproducibility of the Peritoneal Regression Grading Score for assessment of response to therapy in peritoneal metastasis","volume":"74","author":"Solass","year":"2019","journal-title":"Histopathology"},{"key":"2026061312294844700_aqag055-B56","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.suronc.2020.02.014","article-title":"Impact of preoperative chemotherapy on the histological response of patients with peritoneal metastases from colorectal cancer according to Peritoneal Regression Grading Score (PRGS) and TRG","volume":"33","author":"Taibi","year":"2020","journal-title":"Surg Oncol"},{"key":"2026061312294844700_aqag055-B57","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1515\/pp-2022-0117","article-title":"Histological tumor response predicts clinical outcome in patients with colorectal peritoneal metastasis treated with preoperative chemotherapy followed by cytoreduction and HIPEC","volume":"8","author":"Ferreira de Sousa","year":"2023","journal-title":"Pleura Peritoneum"},{"key":"2026061312294844700_aqag055-B58","volume-title":"Digestive System Tumours","author":"Organisation mondiale de la sant\u00e9, Centre international de recherche sur le cancer","year":"2019","edition":"5th"},{"key":"2026061312294844700_aqag055-B59","author":"Cancer protocol templates"},{"key":"2026061312294844700_aqag055-B60","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1002\/jso.27776","article-title":"Preoperative chemotherapy response and survival in patients with colorectal cancer peritoneal metastases","volume":"130","author":"Tinsley","year":"2024","journal-title":"J Surg Oncol"},{"key":"2026061312294844700_aqag055-B61","doi-asserted-by":"publisher","first-page":"9138","DOI":"10.1245\/s10434-021-10367-6","article-title":"Ratio of pathological response to preoperative chemotherapy in patients undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer correlates with survival","volume":"28","author":"Mor","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"2026061312294844700_aqag055-B62","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1245\/s10434-025-18427-x","article-title":"Radiologic and pathologic response as predictors of survival in patients with colorectal peritoneal metastases undergoing neoadjuvant chemotherapy followed by CRS-HIPEC: a retrospective study","volume":"33","author":"Cyr-Cronier","year":"2026","journal-title":"Ann Surg Oncol"},{"key":"2026061312294844700_aqag055-B63","doi-asserted-by":"publisher","first-page":"e658","DOI":"10.1097\/MD.0000000000000658","article-title":"Prognostic comparison between mucinous and nonmucinous adenocarcinoma in colorectal cancer","volume":"94","author":"Park","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"2026061312294844700_aqag055-B64","doi-asserted-by":"publisher","first-page":"e699","DOI":"10.1016\/j.clcc.2018.07.005","article-title":"Prognostic implications of mucinous differentiation in metastatic colorectal carcinoma can be explained by distinct molecular and clinicopathologic characteristics","volume":"17","author":"Khan","year":"2018","journal-title":"Clin Colorectal Cancer"},{"key":"2026061312294844700_aqag055-B65","doi-asserted-by":"publisher","first-page":"205","DOI":"10.21037\/atm.2020.01.52","article-title":"Clinicopathological characteristics and prognosis of colorectal mucinous adenocarcinoma and nonmucinous adenocarcinoma: a Surveillance, Epidemiology, and End Results (SEER) population-based study","volume":"8","author":"Li","year":"2020","journal-title":"Ann Transl Med"},{"key":"2026061312294844700_aqag055-B66","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.ejso.2022.10.007","article-title":"External validation of COMPASS and BIOSCOPE prognostic scores in colorectal peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"49","author":"Tonello","year":"2023","journal-title":"Eur J Surg Oncol"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/165\/6\/aqag055\/68521465\/aqag055.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/165\/6\/aqag055\/68521465\/aqag055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T16:06:44Z","timestamp":1781453204000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/doi\/10.1093\/ajcp\/aqag055\/8707462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqag055","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,6]]},"article-number":"aqag055"}}